Neuberger Berman Group
NUVB icon

Neuberger Berman Group’s Nuvation Bio NUVB Stock Holding History

Neuberger Berman Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60K Sell
13,994
-4,380
-24% -$24.4K ﹤0.01% 2105
2025
Q4 		$165K Buy
18,374
+7,561
+70% +$46.8K ﹤0.01% 1982
2025
Q3 		$40K Buy
+10,813
New +$29.5K ﹤0.01% 2003
2025
Q2 		– Sell
-11,711
Closed -$20.6K – 2103
2025
Q1 		$20.6K Hold
11,711
– – ﹤0.01% 1936
2024
Q4 		$31.2K Buy
+11,711
New +$30.2K ﹤0.01% 1899

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Neuberger Berman Group's NUVB Position: Q1 2026 in Review

Neuberger Berman Group reduced its Nuvation Bio (NUVB) stake by 24% in Q1 2026, selling an estimated $24.4K and leaving 13,994 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Neuberger Berman Group first reported a position in NUVB in Q4 2024 and has held it in 5 quarters since. The position peaked at $165K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Neuberger Berman Group held 13,994 shares of Nuvation Bio worth $60K as of Q1 2026.
  • Neuberger Berman Group sold 4,380 Nuvation Bio shares in Q1 2026, an estimated $24.4K.
  • Nuvation Bio made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2105 holding.
  • Neuberger Berman Group first reported a position in Nuvation Bio in Q4 2024 and has held it in 5 quarters since.
  • Neuberger Berman Group's Nuvation Bio position peaked at $165K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.